Evotec Innovation Week

Dec 06, 2021—Dec 10, 2021

Categories , , ,

Take a ride on the Evotec “Data-driven R&D Autobahn to Cures” 

5 virtual sessions over 5 days discussing:

  • How Evotec is using data and science across treatment modalities to accelerate innovation in the area of precision medicine to deliver enhanced speed, lower cost, and predictive efficacy
  • Our efforts in AI/ML in the design and development of both small molecules and antibodies, the importance of  biomarker development, targeting RNA, and our approaches to target validation

The sessions take place each day from Monday 6th to Friday 10th December 2021

4 pm GMT 5 pm CET | 11 am EST | 8 am PST.

Each session will take c. 45 min including a Q&A session.

Please note you will need to register for each session individually.

Day 1 | Monday, 6 December
4 pm GMT | 5 pm CET |11 am EST | 8 am PST
Drug discovery in the Evotec multiverse: Knowledge-driven integrated R&DAdam Davenport | EVP, Head of Global Molecular Discovery
Tim James | VP, Head of Data Science
Christophe Boldron | VP, Head of Medicinal Chemistry
Day 2 | Tuesday, 7 December
4 pm GMT | 5 pm CET |11 am EST | 8 am PST
The importance of precision medicine: How biomarkers optimize translation from bench to bedside and backElizabeth van der Kam | SVP, Translational Biomarkers
Christoph Schaab | SVP, Head of Proteomics and Metabolomics
Day 3 | Wednesday, 8 December
4 pm GMT | 5 pm CET |11 am EST | 8 am PST
The early bird catches the helix: Expanding the druggable target space to RNASteffen Grimm | Group Leader, Hit ID and Biophysics
Hilary Brooks | Senior Research Scientist, In Vitro Pharmacology
Day 4 | Thursday, 9 December
4 pm GMT | 5 pm CET |11 am EST | 8 am PST
Do firefighters cause fires? Establishing real disease associations through target validationHauke Cornils | VP, Early DiscoveryRESERVE YOUR SEAT
Day 5 | Friday, 10 December
4 pm GMT | 5 pm CET |11 am EST | 8 am PST

Translate your idea into product: AI-driven antibody discovery at EvotecBarbara Bachler-Konetzki | Group Leader, In Vitro Pharmacology
Randal Ketchem | 
SVP, Discovery and Molecular Design
Maria Pilla | 
EVP, Global Head of Preclinical Development